Host-Directed Therapy in Nontuberculous Mycobacterial Pulmonary Disease: Preclinical and Clinical Data Review. [PDF]
Anidi IU, Olivier KN.
europepmc +1 more source
Delivery of human apolipoprotein (apo) E to liver by an [E1(-), E3(-), polymerase(-), pTP(-)] adenovirus vector containing a liver-specific promoter inhibits atherogenesis in immunocompetent apoE-deficient mice [PDF]
Recombinant adenovirus (rAd)-mediated apoE gene transfer to the liver of apoE(-/-) mice is anti-atherogenic. However, first generation rAd vectors were associated with immune clearance of transduced hepatocytes, while an improved [E1(-), E3(-) polymerase(
Amalfitano, A +4 more
core
Host-Directed Therapies for Tackling Multi-Drug Resistant Tuberculosis: Learning From the Pasteur-Bechamp Debates: Table 1. [PDF]
Alimuddin Zumla, Markus Maeurer
openalex +1 more source
Combination of MCL-1 and BCL-2 inhibitors is a promising approach for a host-directed therapy for tuberculosis. [PDF]
Arnett E +9 more
europepmc +1 more source
Salmonella enterica, a major cause of gastroenteritis and typhoid fever, hijacks host machinery to invade cells, and replicate within a specialized niche.
Sehee Yun +6 more
doaj +1 more source
LncRNA: A Potential Target for Host-Directed Therapy of Candida Infection. [PDF]
Wang Y, Xu H, Chen N, Yang J, Zhou H.
europepmc +1 more source
Host-directed therapy to combat mycobacterial infections. [PDF]
Kilinç G +3 more
europepmc +1 more source
Proapoptotic Bcl-2 inhibitor as host directed therapy for pulmonary tuberculosis [PDF]
Sanjay K. Jain +11 more
openalex +1 more source

